Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.34

-0.23

-0.12

-0.01

Details

Expected EPS

-0.005714

Actual EPS

-0.11

Surprise EPS

-0.1

Surprise Percent

+1,825.1%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.11 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.